Hydrogen therapy may be an effective and specific novel treatment for aplastic anemia.
Liren Qian, Jianliang Shen, Jianming Cai · Medical science monitor : international medical journal of experimental and clinical research · 2012
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
They found fewer graft-infiltrating T cells in allografts obtained from hydrogen water-treated recipients compared to those obtained from regular water-treated controls. This source-grounded publication contributes evidence relevant to molecular hydrogen and is retained in a transparent general research category when a more specific study design is not supported by the indexed record.
What the Findings Mean
H2HUBB reviewed how molecular hydrogen was evaluated in this publication and summarizes the source-grounded findings below. Aplastic anemia (AA) is a rare bone marrow failure disorder with high mortality rate, which is characterized by pancytopenia and an associated increase in the risk of hemorrhage, infection, organ dysfunction and death.
What Effects Did Molecular Hydrogen Have?
Recent studies also proved that by down-regulation of cytokines, such as IL-6, tumour necrosis factor-α (TNF-α), IFN-γ, hydrogen could inhibit oxidative stress-induced inflammatory tissue injury [ 11 – 13 ]. They found fewer graft-infiltrating T cells in allografts obtained from hydrogen water-treated recipients compared to those obtained from regular water-treated controls [ 13 ]. Hydrogen is highly diffusible and could potentially reach subcellular compartments, such as mitochondria and nuclei, which are the primary site of reactive oxygen species (ROS) generation and DNA damage [ 1 ]. Aplastic anemia (AA) is a rare bone marrow failure disorder with high mortality rate, which is characterized by pancytopenia and an associated increase in the risk of hemorrhage, infection, organ dysfunction and death. The authors concluded that the oxidation phenomenon and/or the formation of free radicals have been suggested to be causally related to various hematological disorders, including aplastic anemia.
Why These Findings Matter
These findings add evidence supporting molecular hydrogen's therapeutic potential within the biological process and outcomes directly measured in this publication and contribute to the growing body of molecular-hydrogen research.
How Strong Is This Evidence?
H2HUBB classifies this publication as other research and interprets only the outcomes directly supported by the source record.
Technical Study Details
H2HUBB classifies this publication as other research with other supported evidence.
Limitations and Safety
No separate limitations or safety findings were identified in the current-study source text available to H2HUBB.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.
What the Researchers Studied
The available source identifies this publication as other research. A more specific population or model was not separately reported in the source text available to H2HUBB.